Insights and news

Stephenson Harwood advises Shield Therapeutics plc on exclusive Japan licence

Law firm Stephenson Harwood LLP has advised Shield Therapeutics plc on its exclusive licence agreement with VITAL-NET, Inc. for ACCRUFeR® in Japan.